Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

20008,644 citationsJournal Articlegreen Open Access

Authors

Abstract

Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure.

Topics & Keywords

Blood Pressure and Hypertension Studies Renin-Angiotensin System Studies Heart Failure Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 342, Issue 3, pp. 145-153

DOI: 10.1056/nejm200001203420301

Field-Weighted Citation Impact: 435.28